Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity

Documenti analoghi

• Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
  di: Kumar, Nathella P., et al.
  Pubblicazione: (2018)
• Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
  di: Pavan Kumar, Nathella, et al.
  Pubblicazione: (2019)
• Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
  di: Kumar, Nathella Pavan, et al.
  Pubblicazione: (2019)
• Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis
  di: Kumar, Nathella P., et al.
  Pubblicazione: (2019)
• Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment
  di: Kumar, Nathella Pavan, et al.
  Pubblicazione: (2016)